Home - X4 Pharmaceuticals

With grit and integrity, we advance novel therapies for individuals with chronic neutropenic disorders. The page tagline says, “Progress for Patients” over an image of the sun rising behind Half Dome in Yosemite National Park. There is a button to "learn more" that directs to the website’s Focus page.

PROGRESS

PATIENTS

Enabling a better future for people with rare immune disorders

recent news

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 1, 2024
X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
October 24, 2024
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2024

© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved. Terms of Use | Privacy | Compliance and Ethics